ARCHIVES

NCCS Names 7 To Board; FDA Approves Warning Labels for Hormone Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 03 | January 17, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

For Research Projects In Cancer Therapy

March 1, 1996

Professional Societies: ASCO Seeks Balance In Roles As U.S., International Society

May 23, 1997

House Bill Provides 5.7% Increase To NIH, But Passage Threatened By Amendments

August 4, 1995

Centers Core Support To Be Trimmed By Dropping Funds for Scientists Salaries, Shared Resources

September 23, 1977

NIH Review Process A Disaster, Borek Says

October 19, 1979